Midges, mapped: gene-edited biting insects give researchers a new grip on livestock disease

A blood-feeding fly no larger than a pinhead became the first Culicoides biting midge ever to carry a precisely edited genome on 20 July 2026, when a UK research team announced it had used CRISPR-Cas9 to knock out a specific gene in the species. The work, carried out at the Pirbright Institute in Surrey, hands researchers a tool they have wanted for years: a way to test, gene by gene, how the midges acquire and transmit the viruses that cost farmers billions of dollars each year.

The midge in question matters because of what it carries. Bluetongue virus, Schmallenberg virus, and the African horse sickness virus all move between livestock through Culicoides bites, not through the animals themselves. Vaccines exist for some strains, but the insects have been the black box in the transmission chain. Until now, researchers could only describe what the vectors did; they could not perturb the genetics and watch what broke.

What the tool actually does

The Pirbright group used CRISPR-Cas9 to introduce a fluorescent marker gene into the midge, then bred successive generations carrying the edit. The technique mirrors work done in mosquitoes for malaria research, but Culicoides are smaller, harder to rear in colonies, and far less studied at the genetic level. A reproducible editing protocol effectively gives the field a reference animal: one whose genome researchers can reliably target, compare across labs, and use to screen which genes make the midge vulnerable to infection.

The practical pay-off is slow. Gene-edited insects do not get released into European farmland in the year after the protocol is published. What changes immediately is what scientists can ask in the lab. They can now silence candidate genes one at a time and measure whether a virus still replicates inside the midge, or whether the edited insect transmits less efficiently. That kind of step-by-step dissection is the standard playbook of modern vector biology, and Culicoides researchers have been working without it.

Why livestock, why now

Bluetongue virus has cycled through European herds repeatedly this decade. Outbreaks in 2023 and 2024 hit sheep and cattle across southern Europe and pushed authorities in several countries into mass vaccination campaigns. African horse sickness, which is devastating to horses and donkeys, has crept north as warming climates expand the range of the midges that carry it. The economic weight of these diseases sits with farmers, particularly in southern and eastern Europe, in the Mediterranean basin, and across the Middle East and parts of Asia.

Most control efforts have relied on insecticides, animal movement restrictions, and vaccines where they exist. Insecticides face the same resistance problems seen in mosquitoes. Vaccines are strain-specific and can be overtaken by new serotypes. The midge itself, the common denominator, has been the hardest variable to manipulate, which is what makes a working gene-edit protocol a meaningful entry in the toolkit rather than a curiosity.

The counterweight

Gene-edited insects are not without critics. Environmental groups have raised concerns about release programmes, on both ecological and ethical grounds, and the European regulatory environment for genetically modified arthropods remains cautious. The Pirbright work itself is a contained laboratory study: no edited midge leaves the facility. The research is best understood as upstream science, producing knowledge that might, years from now, feed into control strategies such as gene drives that suppress midge populations or render them resistant to the viruses they transmit.

That distance matters. It also points to where the geopolitical weight of this kind of research sits: in countries with the laboratory infrastructure to do the work, and the regulatory patience to let it mature. Pirbright is part of that small club, alongside a handful of US, Australian, and Chinese institutions with comparable vector-genetics programmes. The science is global in collaboration, but the bench work is concentrated.

What to watch

The next milestones will be functional, not technical. Researchers will start publishing which midge genes, when knocked out, reduce viral replication. Those papers are what farmers, veterinary authorities, and funders will be reading. If the Pirbright protocol spreads to other labs, the field gets a standardised reference animal for the first time, which by itself accelerates everything downstream. If it does not, the work remains a single-lab achievement waiting to be replicated.

For now, the immediate story is modest and concrete: a small fly, a precise cut in its DNA, and a research community that has spent decades asking how a virus gets from one cow to the next. The chain is one link less opaque than it was at the start of the week.

This piece reports a single scientific announcement from the Pirbright Institute. Coverage focuses on what the tool enables inside laboratories, not on field release, which remains outside the scope of the cited study.